ClinicalTrials.gg
Drug

Zolpidem clinical trials

Also written Ambien and Myslee.

studies test it
86
open now
6
in phase 3
9
first study started
2001

How each study uses Zolpidem is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study

Get an email when these change. Save the Zolpidem studies recruiting or about to start — once a week, free: studies that open, close, add sites or post results.

Get alerts for these studies
See an example email

Example · made-up studies

Breast cancer · Recruiting: 2 came in, 3 changed

What changed in your alerts, Oct 31 – Nov 6:

A study of drug A after surgery for early breast cancer

Came in · now Recruiting

Drug B with hormone therapy in advanced breast cancer

Changed

· Sites: 4 added, including Seoul and Busan

· Enrollment: 300 → 450 participants

Exercise during chemotherapy

Now Active, not recruiting

One email a week for all your alerts. Stop any time.

Approvals

The first approval found in each region, with its record

United States
16 Dec 1992 · AMBIEN · NDA 019908 (FDA, Drugs@FDA)
European Union
Not in EMA's list of EU-wide authorizations

From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out

How studies write it

Studies that test it under each name

Name

Zolpidem
51
zolpidem tartrate
8
Ambien CR
5
Zolpidem 10 mg tablets
3
Zolpidem 10 mg
3

Brand

Ambien
22
Myslee
2
Stilnoct
1
Stilnox
1

Studies by the year they started

85 studies that test it; most in 2006 (8)

Studies that test Zolpidem, by start year
YearStudies
20012
20024
20033
20047
20056
20068
20073
20085
20092
20103
20113
20124
20131
20142
20154
20162
20177
20183
20194
20213
20222
20232
20242
20251
20262

By phase

A phase 1/2 study counts in both.

Early Phase 1
3
Phase 1
16
Phase 2
13
Phase 3
9
Phase 4
32
No phase
16

What it is tested for

Each study’s main condition, where its own words name it, so a study counts once.

Who runs them

Industry 33 · Other 53

Sanofi (9) · University of Pennsylvania (4) · Johns Hopkins University (3) · Massachusetts General Hospital (3) · University of California, San Francisco (2) · Janssen Research & Development, LLC (2) · Teva Pharmaceuticals USA (2) · Eisai Inc. (2)

Often tested with

Tested in the same studies.

Trazodone (4) · Suvorexant (3) · Doxepin (3) · Melatonin (3) · Pregabalin (2) · Lemborexant (2) · Midazolam (2) · Fluoxetine (2)

Coming up

From the study records. Dates are the sponsors’ own estimates and often move.

Reaching primary completion within a year · 2, 1 in phase 3

Studies that test Zolpidem, phase 3 first.

Studies

Open first, then newest update. How each study uses Zolpidem is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.

Testing it · 86

See all 86 studies that test Zolpidem →

Given beside what is tested · 7 — Zolpidem is usual care or a partner of the new treatment
As the comparator · 20 — what is tested is compared with Zolpidem

Codes

What other systems call Zolpidem · ClinicalTrials.gg INT006701

  • MeSH (NLM) D000077334ZolpidemConfirmed ClinicalTrials.gov, NLM, Wikidata
  • UNII (FDA) 7K383OQI23ZOLPIDEMConfirmed FDA, NLM, Wikidata
  • RxNorm 39993Confirmed FDA, Wikidata
  • Wikidata Q218842zolpidemConfirmed FDA, NLM, Wikidata
  • NCI Thesaurus C62000ZolpidemOne source FDA
  • DrugBank DB00425One source Wikidata

Also registered as zolpidem tartrate (UNII WY6W63843K · RxNorm 221183).

“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.